Myelodysplastic Syndromes (MDS) are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells. A diagnosis is usually made using a bone marrow biopsy and there are typically not any early signs or symptoms. At Smilow Cancer Hospital, there are different treatment options available to patients, including clinical trials. Patients are treated based on their individual clinical and genetic features and classified as either lower risk or higher risk. Certain patients can be cured with aggressive treatment with chemotherapy followed by stem cell transplant using stem cells from a donor.
Our researchers are continually working to improve outcomes of patients by conducting research related to MDS. Smilow Cancer Hospital is an MDS Foundation Center of Excellence Member, an international group of physicians and researchers that was established to provide an ongoing exchange of information relating to MDS.